Emerging agents like Tirzepatide, which activates both GLP-1 and GIP receptors, and Orforglipron, a nonpeptide oral GLP-1 agonist in phase 2 trials, further expand the therapeutic potential of this class (23)(24)
Noom defines a microdose as a dose of medication that is a fraction25% or lessof our standard GLP1 plans
All peptides require reconstitution with Bacteriostatic Water (BAC water), sold separately
How to read the tables The comparison tables focus on the information a patient can use immediately: price visibility, clinician review, medication path, support access, cancellation clarity, and source quality
Tissue-Specific Targeting: Demonstrates preferential activity in muscle, bone, and cartilage tissues, making it ideal for musculoskeletal applications
Although relative risk estimates varied slightly across studies, absolute event rates remained very low in all groups